Intrinsic value of WellCare Health Plans - WCG

Previous Close

$153.41

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$153.41

 
Intrinsic value

$150.41

 
Up/down potential

-2%

 
Rating

hold

 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of WCG stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.8

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.50
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  0
  14,522
  14,856
  15,238
  15,666
  16,141
  16,662
  17,230
  17,844
  18,506
  19,216
  19,976
  20,786
  21,650
  22,567
  23,540
  24,572
  25,664
  26,819
  28,039
  29,327
  30,687
  32,120
  33,632
  35,224
  36,901
  38,666
  40,525
  42,480
  44,537
  46,701
Variable operating expenses, $m
 
  6,447
  6,594
  6,763
  6,952
  7,161
  7,391
  7,642
  7,913
  8,205
  8,518
  8,814
  9,172
  9,553
  9,957
  10,387
  10,842
  11,324
  11,834
  12,372
  12,940
  13,540
  14,173
  14,840
  15,542
  16,282
  17,061
  17,881
  18,744
  19,652
  20,606
Fixed operating expenses, $m
 
  7,764
  7,958
  8,157
  8,361
  8,570
  8,785
  9,004
  9,229
  9,460
  9,697
  9,939
  10,188
  10,442
  10,703
  10,971
  11,245
  11,526
  11,814
  12,110
  12,413
  12,723
  13,041
  13,367
  13,701
  14,044
  14,395
  14,755
  15,123
  15,502
  15,889
Total operating expenses, $m
  13,708
  14,211
  14,552
  14,920
  15,313
  15,731
  16,176
  16,646
  17,142
  17,665
  18,215
  18,753
  19,360
  19,995
  20,660
  21,358
  22,087
  22,850
  23,648
  24,482
  25,353
  26,263
  27,214
  28,207
  29,243
  30,326
  31,456
  32,636
  33,867
  35,154
  36,495
Operating income, $m
  530
  310
  303
  317
  353
  409
  486
  584
  702
  841
  1,001
  1,223
  1,427
  1,655
  1,906
  2,183
  2,485
  2,814
  3,171
  3,557
  3,974
  4,424
  4,907
  5,425
  5,981
  6,575
  7,210
  7,889
  8,613
  9,384
  10,206
EBITDA, $m
  618
  385
  378
  394
  430
  488
  566
  665
  784
  925
  1,087
  1,271
  1,477
  1,707
  1,961
  2,240
  2,544
  2,876
  3,236
  3,625
  4,045
  4,498
  4,984
  5,506
  6,066
  6,664
  7,304
  7,987
  8,716
  9,492
  10,319
Interest expense (income), $m
  57
  52
  56
  61
  67
  74
  81
  89
  97
  107
  117
  127
  139
  151
  164
  178
  193
  209
  225
  243
  261
  281
  301
  323
  346
  370
  396
  422
  451
  480
  512
Earnings before tax, $m
  530
  259
  247
  256
  286
  336
  405
  495
  605
  734
  885
  1,095
  1,288
  1,503
  1,742
  2,004
  2,292
  2,605
  2,946
  3,315
  3,713
  4,143
  4,605
  5,102
  5,634
  6,205
  6,815
  7,466
  8,162
  8,904
  9,694
Tax expense, $m
  288
  70
  67
  69
  77
  91
  109
  134
  163
  198
  239
  296
  348
  406
  470
  541
  619
  703
  795
  895
  1,003
  1,119
  1,243
  1,378
  1,521
  1,675
  1,840
  2,016
  2,204
  2,404
  2,617
Net income, $m
  242
  189
  180
  187
  209
  245
  296
  361
  441
  536
  646
  799
  940
  1,098
  1,272
  1,463
  1,673
  1,902
  2,150
  2,420
  2,711
  3,024
  3,362
  3,724
  4,113
  4,529
  4,975
  5,451
  5,958
  6,500
  7,077

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,153
  6,276
  6,420
  6,585
  6,770
  6,975
  7,201
  7,446
  7,711
  7,997
  8,304
  8,633
  8,983
  9,356
  9,752
  10,173
  10,619
  11,091
  11,590
  12,117
  12,674
  13,261
  13,881
  14,534
  15,222
  15,947
  16,710
  17,513
  18,358
  19,247
  20,182
Adjusted assets (=assets-cash), $m
  6,153
  6,276
  6,420
  6,585
  6,770
  6,975
  7,201
  7,446
  7,711
  7,997
  8,304
  8,633
  8,983
  9,356
  9,752
  10,173
  10,619
  11,091
  11,590
  12,117
  12,674
  13,261
  13,881
  14,534
  15,222
  15,947
  16,710
  17,513
  18,358
  19,247
  20,182
Revenue / Adjusted assets
  0.000
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
  2.314
Average production assets, $m
  215
  218
  223
  229
  235
  242
  250
  258
  268
  278
  288
  300
  312
  325
  339
  353
  369
  385
  402
  421
  440
  460
  482
  504
  528
  554
  580
  608
  637
  668
  701
Working capital, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total debt, $m
  998
  1,081
  1,178
  1,290
  1,415
  1,553
  1,705
  1,871
  2,050
  2,243
  2,450
  2,672
  2,908
  3,160
  3,428
  3,712
  4,013
  4,331
  4,668
  5,024
  5,400
  5,796
  6,215
  6,655
  7,120
  7,609
  8,124
  8,666
  9,237
  9,837
  10,468
Total liabilities, $m
  4,153
  4,236
  4,333
  4,445
  4,570
  4,708
  4,860
  5,026
  5,205
  5,398
  5,605
  5,827
  6,063
  6,315
  6,583
  6,867
  7,168
  7,486
  7,823
  8,179
  8,555
  8,951
  9,370
  9,810
  10,275
  10,764
  11,279
  11,821
  12,392
  12,992
  13,623
Total equity, $m
  2,000
  2,040
  2,086
  2,140
  2,200
  2,267
  2,340
  2,420
  2,506
  2,599
  2,699
  2,806
  2,919
  3,041
  3,170
  3,306
  3,451
  3,605
  3,767
  3,938
  4,119
  4,310
  4,511
  4,724
  4,947
  5,183
  5,431
  5,692
  5,966
  6,255
  6,559
Total liabilities and equity, $m
  6,153
  6,276
  6,419
  6,585
  6,770
  6,975
  7,200
  7,446
  7,711
  7,997
  8,304
  8,633
  8,982
  9,356
  9,753
  10,173
  10,619
  11,091
  11,590
  12,117
  12,674
  13,261
  13,881
  14,534
  15,222
  15,947
  16,710
  17,513
  18,358
  19,247
  20,182
Debt-to-equity ratio
  0.499
  0.530
  0.560
  0.600
  0.640
  0.690
  0.730
  0.770
  0.820
  0.860
  0.910
  0.950
  1.000
  1.040
  1.080
  1.120
  1.160
  1.200
  1.240
  1.280
  1.310
  1.340
  1.380
  1.410
  1.440
  1.470
  1.500
  1.520
  1.550
  1.570
  1.600
Adjusted equity ratio
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325
  0.325

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  242
  189
  180
  187
  209
  245
  296
  361
  441
  536
  646
  799
  940
  1,098
  1,272
  1,463
  1,673
  1,902
  2,150
  2,420
  2,711
  3,024
  3,362
  3,724
  4,113
  4,529
  4,975
  5,451
  5,958
  6,500
  7,077
Depreciation, amort., depletion, $m
  88
  74
  75
  76
  77
  78
  80
  81
  82
  84
  86
  48
  50
  52
  55
  57
  59
  62
  65
  68
  71
  74
  78
  81
  85
  89
  94
  98
  103
  108
  113
Funds from operations, $m
  1,103
  263
  255
  263
  286
  323
  376
  442
  524
  620
  731
  848
  991
  1,150
  1,326
  1,520
  1,732
  1,964
  2,215
  2,488
  2,782
  3,099
  3,440
  3,806
  4,198
  4,619
  5,068
  5,549
  6,061
  6,608
  7,190
Change in working capital, $m
  355
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from operations, $m
  748
  398
  255
  263
  286
  323
  376
  442
  524
  620
  731
  848
  991
  1,150
  1,326
  1,520
  1,732
  1,964
  2,215
  2,488
  2,782
  3,099
  3,440
  3,806
  4,198
  4,619
  5,068
  5,549
  6,061
  6,608
  7,190
Maintenance CAPEX, $m
  0
  -35
  -35
  -36
  -37
  -38
  -39
  -40
  -42
  -43
  -45
  -46
  -48
  -50
  -52
  -55
  -57
  -59
  -62
  -65
  -68
  -71
  -74
  -78
  -81
  -85
  -89
  -94
  -98
  -103
  -108
New CAPEX, $m
  -105
  -3
  -5
  -6
  -6
  -7
  -8
  -9
  -9
  -10
  -11
  -11
  -12
  -13
  -14
  -15
  -15
  -16
  -17
  -18
  -19
  -20
  -22
  -23
  -24
  -25
  -26
  -28
  -29
  -31
  -32
Cash from investing activities, $m
  -27
  -38
  -40
  -42
  -43
  -45
  -47
  -49
  -51
  -53
  -56
  -57
  -60
  -63
  -66
  -70
  -72
  -75
  -79
  -83
  -87
  -91
  -96
  -101
  -105
  -110
  -115
  -122
  -127
  -134
  -140
Free cash flow, $m
  721
  360
  215
  221
  243
  278
  329
  394
  473
  567
  676
  790
  930
  1,087
  1,260
  1,451
  1,660
  1,888
  2,136
  2,404
  2,694
  3,007
  3,344
  3,705
  4,093
  4,508
  4,953
  5,427
  5,934
  6,474
  7,050
Issuance/(repayment) of debt, $m
  -203
  83
  97
  111
  125
  139
  152
  166
  179
  193
  207
  222
  236
  252
  268
  284
  301
  319
  337
  356
  376
  397
  418
  441
  464
  489
  515
  542
  570
  600
  631
Issuance/(repurchase) of shares, $m
  -7
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  833
  83
  97
  111
  125
  139
  152
  166
  179
  193
  207
  222
  236
  252
  268
  284
  301
  319
  337
  356
  376
  397
  418
  441
  464
  489
  515
  542
  570
  600
  631
Total cash flow (excl. dividends), $m
  1,554
  443
  313
  333
  368
  417
  481
  559
  652
  760
  883
  1,012
  1,167
  1,338
  1,528
  1,735
  1,961
  2,207
  2,473
  2,760
  3,070
  3,404
  3,762
  4,146
  4,558
  4,998
  5,468
  5,969
  6,504
  7,074
  7,681
Retained Cash Flow (-), $m
  -272
  -40
  -47
  -54
  -60
  -67
  -73
  -80
  -86
  -93
  -100
  -107
  -114
  -121
  -129
  -137
  -145
  -153
  -162
  -171
  -181
  -191
  -201
  -212
  -224
  -236
  -248
  -261
  -275
  -289
  -304
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  403
  266
  279
  307
  350
  408
  479
  566
  667
  783
  905
  1,053
  1,217
  1,399
  1,598
  1,816
  2,053
  2,311
  2,589
  2,889
  3,213
  3,561
  3,934
  4,334
  4,762
  5,220
  5,708
  6,230
  6,785
  7,377
Discount rate, %
 
  5.60
  5.88
  6.17
  6.48
  6.81
  7.15
  7.50
  7.88
  8.27
  8.69
  9.12
  9.58
  10.06
  10.56
  11.09
  11.64
  12.22
  12.84
  13.48
  14.15
  14.86
  15.60
  16.38
  17.20
  18.06
  18.96
  19.91
  20.91
  21.95
  23.05
PV of cash for distribution, $m
 
  382
  237
  233
  239
  252
  269
  289
  308
  326
  341
  346
  351
  350
  343
  330
  312
  289
  263
  234
  205
  175
  147
  120
  96
  75
  57
  42
  31
  21
  15
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs. It operates through three segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. The Medicaid Health Plans segment offers plans for beneficiaries of temporary assistance for needy families, supplemental security income, and aged blind and disabled residents; and other state-based programs, such as children's health insurance programs for qualifying families who are not eligible for Medicaid, as well as managed long-term care programs for people with chronic illnesses or who have disabilities and need health and long-term care services. The Medicare Health Plans segment provides Medicare, a federal program that provides eligible persons aged 65 and over, as well as some disabled persons with a range of hospital, medical, and prescription drug benefits; Medicare Advantage, a MedicareĀ’s managed care alternative to the original Medicare program, which offers individuals standard Medicare benefits directly through Centers for Medicare & Medicaid Services; and coordinated care plans that are administered through health maintenance organizations and require members to seek health care services and select a primary care physician from a network of health care providers. The Medicare PDPs segment provides Medicare part D PDP plans to Medicare-eligible beneficiaries. Its PDP plans offer national in-network prescription drug coverage with 69,000 pharmacies, including a preferred pharmacy network. As of December 31, 2015, the company served approximately 3.8 million members in 50 states and the District of Columbia. WellCare Health Plans, Inc. was founded in 1985 and is headquartered in Tampa, Florida.

FINANCIAL RATIOS  of  WellCare Health Plans (WCG)

Valuation Ratios
P/E Ratio 28.1
Price to Sales 0.5
Price to Book 3.4
Price to Tangible Book
Price to Cash Flow 9.1
Price to Free Cash Flow 10.6
Growth Rates
Sales Growth Rate 2.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -23.4%
Cap. Spend. - 3 Yr. Gr. Rate 11.1%
Financial Strength
Quick Ratio NaN
Current Ratio NaN
LT Debt to Equity 49.9%
Total Debt to Equity 49.9%
Interest Coverage 10
Management Effectiveness
Return On Assets 4.7%
Ret/ On Assets - 3 Yr. Avg. 3.2%
Return On Total Capital 8.2%
Ret/ On T. Cap. - 3 Yr. Avg. 5.1%
Return On Equity 13%
Return On Equity - 3 Yr. Avg. 8.1%
Asset Turnover 2.5
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 4.7%
EBITDA Margin - 3 Yr. Avg. 3.4%
Operating Margin 3.7%
Oper. Margin - 3 Yr. Avg. 2.5%
Pre-Tax Margin 3.7%
Pre-Tax Margin - 3 Yr. Avg. 2.5%
Net Profit Margin 1.7%
Net Profit Margin - 3 Yr. Avg. 1%
Effective Tax Rate 54.3%
Eff/ Tax Rate - 3 Yr. Avg. 61%
Payout Ratio 0%

WCG stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the WCG stock intrinsic value calculation we used $14237 million for the last fiscal year's total revenue generated by WellCare Health Plans. The default revenue input number comes from 2016 income statement of WellCare Health Plans. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our WCG stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 5.6%, whose default value for WCG is calculated based on our internal credit rating of WellCare Health Plans, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of WellCare Health Plans.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of WCG stock the variable cost ratio is equal to 44.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $7575 million in the base year in the intrinsic value calculation for WCG stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.2% for WellCare Health Plans.

Corporate tax rate of 27% is the nominal tax rate for WellCare Health Plans. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the WCG stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for WCG are equal to 1.5%.

Life of production assets of 6.2 years is the average useful life of capital assets used in WellCare Health Plans operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for WCG is equal to 0%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2000 million for WellCare Health Plans - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 44.576 million for WellCare Health Plans is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of WellCare Health Plans at the current share price and the inputted number of shares is $6.8 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
MOH Molina Healthc 49.79 213.57  str.buy
CNC Centene 74.40 1,996.86  str.buy
AET Aetna 135.07 131.26  hold
UAM Universal Amer 9.97 2.05  str.sell
GTS Triple-S Manag 18.10 13.23  sell
MGLN Magellan Healt 68.80 114.59  str.buy
ANTM Anthem 177.89 262.05  str.buy
HUM Humana 221.98 164.85  sell

COMPANY NEWS

▶ Heres what WellCare did not get in the Universal American deal   [Apr-28-17 02:15PM  American City Business Journals]
▶ Former WellCare executives face deadline to repay $26M from fraud scheme   [Apr-26-17 02:25PM  American City Business Journals]
▶ UnitedHealth Seen as Ready to Weather Obamacare Rewrite   [Apr-17-17 05:13PM  TheStreet.com]
▶ Everyone at this major Tampa employer earns at least $16 an hour   [Apr-13-17 08:00AM  American City Business Journals]
▶ Why WellCare gave its CEO a pay hike   [Apr-10-17 11:20AM  American City Business Journals]
▶ WellCare Tests Artificial Intelligence to Help Improve Patient Health   [Apr-07-17 01:38PM  The Wall Street Journal]
▶ WellCare Sponsors 2017 Midlands Heart Walk   [Mar-31-17 08:30AM  PR Newswire]
▶ Another Run at Health Care Reform: Impact on Healthcare   [Mar-30-17 02:24PM  Investopedia]
▶ Riviera Motel files for bankruptcy to thwart Dr. Kiran Patel   [Mar-16-17 03:20PM  at bizjournals.com]
▶ WellCare Announces Pricing of Notes   [Mar-08-17 05:40PM  PR Newswire]
▶ WellCare Announces Offering of Notes   [07:30AM  PR Newswire]
▶ Why federal regulators want to fine WellCare $1 million   [Mar-03-17 03:21PM  at bizjournals.com]
▶ 10 Biggest HMOs in USA   [Feb-21-17 04:30PM  at Insider Monkey]
▶ Humana is on the clock for its next move   [Feb-15-17 04:16PM  at bizjournals.com]
▶ 10 Largest Health Insurance Companies In America   [Jan-30-17 11:08AM  at Insider Monkey]
▶ WellCare Supports Tornado Relief Efforts in Georgia   [Jan-26-17 08:30AM  PR Newswire]
▶ WellCare Names W. Lee Bowers COO, Florida   [08:30AM  PR Newswire]
Stock chart of WCG Financial statements of WCG
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.